目的：临床试验中对组蛋白脱乙酰基酶阻滞剂(HDACi)的研究目的在于诱导细胞分化，生长停止，和肿瘤细胞的凋亡。
Purpose: Histone deacetylase inhibitors (HDACi) are being studied in clinical trials with the aim to induce cellular differentiation, growth arrest, and apoptosis of tumor cells.
本发明提供了用于抑制组蛋白脱乙酰基酶酶活性的化合物和方法。
The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity.
本发明提供了用于抑制组蛋白脱乙酰基酶酶活性的化合物和方法。
The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity.
应用推荐